List view / Grid view
9 June 2015 | By Victoria White
Scientists have discovered that a toxin secreted by Vibrio vulnificus has potential to prevent the growth of tumours by cutting the protein Ras...
9 June 2015 | By
Tillotts Pharma and Numab are to collaborate to develop and commercialise new antibody-based therapies for people with inflammatory bowel disease...
9 June 2015 | By Victoria White
Apitope’s product candidate ATX-F8-117 has been granted Orphan Drug Status by the FDA for the treatment of patients with haemophilia A in the US...
9 June 2015 | By Victoria White
A new study has revealed that calcineurin inhibitor-based medications, such as Tacrolimus or cyclosporine, may also protect against Alzheimer’s disease...
9 June 2015 | By Victoria White
AM‐Pharma has announced that the FDA and EMA have both granted orphan designation status to recAP for the treatment of hypophosphatasia...
9 June 2015 | By Victoria White
Fibrocell and Intrexon have announced positive preclinical data for FCX-007 for the treatment of recessive dystrophic epidermolysis bullosa...
8 June 2015 | By Victoria White
Researchers have discovered that the myxoma virus can kill some kinds of cancer cells while eliminating a complication of bone marrow transplants...
8 June 2015 | By Victoria White
The Global Fertility Alliance is a new collaboration to advance excellence in fertility technologies within the assisted reproductive treatment laboratory...
8 June 2015 | By Select Biosciences
Select Biosciences is delighted to announce that its flagship congress now in its 7th year in San Diego, California, USA is being held September 28-30, 2015...
8 June 2015 | By Select Biosciences
Select Biosciences is delighted to announce that its Organ-on-a-Chip and 3D-Printing in the Life Sciences Conference, Boston, July 8-9, 2015 features all the international key opinion leaders in the organ-on-a-chip/body-on-a-chip field as well as 3D-bioprinting fields...
8 June 2015 | By Victoria White
A $10 billion market exists for a company able to develop a novel, targeted opioid therapy that excludes side effects such as addiction and constipation...
4 June 2015 | By Victoria White
When the T cells of your immune system are forced to deal over time with cancer or a chronic infection, they can develop "T cell exhaustion"...
4 June 2015 | By Victoria White
AmpliPhi's production facility in Ljubljana has been cleared by JAZMP to manufacture bacteriophages under current Good Manufacturing Practices standards...
4 June 2015 | By Victoria White
VBI Vaccines has delivered a presentation that supports the potential use of its eVLP platform in the development of a novel Hepatitis C vaccine candidate...
4 June 2015 | By Victoria White
The existing global collaboration between Celgene and bluebird bio has been amended and restated to focus on developing product candidates targeting BCMA...
